For patients with HNSCC treated with surgery, chemoradiotherapy, radiation, or mixed therapies, elevated PD-L1 expression has been linked to a poorer prognosis in the majority of studies examining its prognostic value (52). The gene discussed is CD274; the disease is head and neck squamous cell carcinoma.